- Home
- Life Sciences
- Biotechnology
- Biotechnology Analysis & Statistics in the United States, May 2013
Talk to Alison
(866) 682 9815
Search inside this page
Publication dates
Publishers
- Global Data (269)
- Global Markets Direct (131)
- Currentpartnering (3)
- France Innovation Scientifique et Transfert (2)
- Ibisworld (3)
-
- MarketLine (61)
- RNCOS (4)
- IData Research, Inc. (16)
- CHI Insight Pharma Reports (13)
- Euromonitor International (2)
- Frost & Sullivan (26)
- La Merie Publishing (6)
- Datamonitor (39)
- Global Industry Analyst (20)
- SCRIP Insights (18)
- ICD Research (17)
- Freedonia (13)
- Business Review (10)
- Espicom Business Intelligence (10)
- Life Science Analytics (LSA) (10)
- GBI Research (9)
- Kalorama Information (7)
- Visiongain (6)
- BioPlan Associates, Inc. (4)
- Industry Experts (4)
- TriMark Publications (4)
- BCC Research (3)
- BioPharm Reports (3)
- Canadean Ltd (3)
- Aruvian's R'search (2)
- Infiniti Research Limited (2)
- Koncept Analytics (2)
- MarketsandMarkets (2)
- Packaged Facts (2)
- Pharmavision (2)
- Plunkett Research (2)
- ABMRG (1)
- BioInformatics (1)
- Daedal Research (1)
- Firstword Pharma (1)
- International Market Analysis Research and Consult (1)
- Ken Research Private (1)
- Urch Publishing (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
All regions
- All
- North America
- United States
data types
Free Market Research Guides to Download
Biotechnology Analysis & Statistics in the United States, May 2013
You might be interested in: biotech, biomedical, biomaterials, more »
» Purchase Premium Reports
1-30 of about 700 reports
U.S. Dental Bone Graft Substitutes and Other Biomaterials Market
- $ 6 995
- Industry report
- May 2013
- by iData Research, Inc.
Declining sales of specific market products has resulted in decelerating growth of the total U.S. denta bone graft substitute and other biomaterials market in 2012. In 2012, the total U.S. market for dental ...
- Industries : Biomaterial
- Countries : United States
iPS cell Generation patent landscape - 2013/03
- $ 6 860
- Industry report
- May 2013
- by France Innovation Scientifique et Transfert
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...
- Industries : Biological Therapy
- Countries : United States, South Korea, China
U.S. qPCR Reagents Market
- $ 6 000
- Industry report
- April 2013
- by Frost & Sullivan
Finding Opportunities in a Changing Competitive and Patent Landscape This research service evaluates the U.S. qPCR reagents market from 2010 to 2017. The mature qPCR reagents market remains dynamic due ...
- Industries : Genetically Modified Organism, Gmo
- Countries : United States
iPS cell Differentiation patent landscape - 2013/03
- $ 4 060
- Industry report
- May 2013
- by France Innovation Scientifique et Transfert
Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...
- Industries : Biological Therapy
- Countries : United States, South Korea, China
Antibody Partnering Terms and Agreements
- $ 2 995
- Industry report
- May 2013
- by Currentpartnering
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare ...
- Industries : Biopharmaceutical
- Countries : United States
Pharmacogenomics Partnering Terms and Agreements
- $ 2 795
- Industry report
- April 2013
- by Currentpartnering
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds ...
- Industries : Genomics
- Countries : United States
Advances in Clinical Genome Sequencing and Diagnostics - Overview
- $ 2 495
- Industry report
- March 2013
- by CHI Insight Pharma Reports
This report explores the recent surge in clinical genome sequencing, from the point of view of the sequencing providers, the medical organizations delivering these services, and the start-ups offering ...
- Industries : Genomics
- Countries : United States
World Biopharmaceutical: Growth Hormone Deficiency - Pipeline Review, H1 2012
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Growth Hormone Deficiency, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Biopharmaceutical
- Countries : World, United States
World Biological Therapy: Natural Killer Cell Lymphomas - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides information on the therapeutic development for Natural Killer Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
- Industries : Biological Therapy
- Countries : United States, World
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2013', provides an overview of the indication's ...
- Industries : Biological Therapy
- Countries : World, United States
Chikungunya - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Chikungunya - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Chikungunya - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...
- Industries : Biopharmaceutical
- Countries : World, United States
Cancer Vaccine Partnering Terms and Agreements
- $ 1 795
- Industry report
- May 2013
- by Currentpartnering
The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends ...
- Industries : Biopharmaceutical
- Countries : United States
Genetic Testing Market Outlook to 2017
- $ 1 200
- Industry report
- May 2013
- by RNCOS
A recent report, ?Genetic Testing Market Outlook to 2017?, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working ...
- Industries : Genomics
- Countries : United States, World
US Personalized Cancer Genome Sequencing Market
- $ 1 200
- Industry report
- May 2013
- by RNCOS
The US personalized cancer Genome Sequencing market is primarily classified into Targeted Genome Sequencing and Whole-Genome Sequencing. Our report entitled ?US Personalized Cancer Genome Sequencing Market? ...
- Industries : Genomics
- Countries : United States
Biotechnology Market in the United States
- $ 1 020
- Industry report
- April 2013
- by Ibisworld
IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's May Biotechnology in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis This Industry Risk Ratings report ...
- Industries : Biopharmaceutical
- Countries : United States
Biotechnology Market in the United States
- $ 1 020
- Industry report
- March 2013
- by Ibisworld
On the brink: Healthcare reform and innovative developments will stimulate demand Biotechnology in the US Wave of the future: Demand for cutting-edge medicines and treatments will result in strong growth ...
- Industries : Biopharmaceutical
- Countries : United States
Sports Nutrition Market Analysis in the US
- $ 898
- Industry report
- April 2013
- by Euromonitor International
Mainstreaming is the word of the day in sports nutrition. As the popularity of products continues to grow among non-hardcore workout demographics, more mass retailers are offering assortments in an attempt ...
- Industries : Sport Nutritional, Biopharmaceutical
- Countries : United States
Hycor Biomedical Inc. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary Hycor Biomedical Inc. (Hycor) is a medical diagnostic company. The company manufactures and markets diagnostic products used in clinical laboratories. It offers urinalysis, allergy testing and ...
- Industries : Biopharmaceutical
- Countries : United States
Cytokine PharmaSciences, Inc. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary Cytokine PharmaSciences, Inc. (CPSI) is a biopharmaceutical company. The company develops drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune ...
- Industries : Biological Therapy
- Countries : United States
Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary Cytograft Tissue Engineering, Inc. (CTE) is a genetic engineering company. The company develops cell-based solutions for the treatment of cardiovascular diseases. It has developed a regenerative ...
- Industries : Biological Therapy
- Countries : United States
Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- April 2013
- by Global Data
Summary Bioheart, Inc. (Bioheart) is a biotechnology company. It focus on the treatment of cardiovascular related diseases. It discovers, develops and commercializes autologous cell therapies to treat ...
- Industries : Biological Therapy
- Countries : United States
Competitor Analysis: Antibody-Drug Conjugates (ADC)
- $ 774
- Industry report
- April 2013
- by La Merie Publishing
Product description The present Competitive Intelligence Report about Antibody-Drug Conjugates (ADC) / Immunoconjugates provides a competitor evaluation in the field of tumor targeting antibodies conjugated ...
- Industries : Biopharmaceutical
- Countries : United States
Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Genomics
- Countries : United States
Bruker Corporation (Symbol:BRKR) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Genomics
- Countries : United States
Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
- Countries : United States
Biocompatibles International Ltd. - Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary Biocompatibles International Ltd. (Biocompatibles) is a medical technology company, engaged in the development of products used for the treatment of cancer and benign tumors. The company is divided ...
- Industries : Biological Therapy
- Countries : United States, United Kingdom
AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review
- $ 300
- Company report
- March 2013
- by Global Data
Summary AdvanSource Biomaterials Corporation (AdvanSource) is a biomaterial manufacturer, based in the US. The company develops polymer based materials for the medical and pharmaceutical industries. Its ...
- Industries : Biomaterial
- Countries : United States
BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biopharmaceutical
- Countries : United States
American Vietnamese Biotech Inc (Symbol:AMV) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Biotechnology
- Countries : United States
Exiqon A/S (Symbol:EXQ) SWOT Analysis, Strategy, Revenues and Profits
- $ 300
- Company report
- March 2013
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Genomics
- Countries : Denmark, New Zealand, Australia, United States, Italy, South Korea, Japan, China
» Download Public Reports
About 2 600 reports
Company Report: Biological Therapy in The United States for Year 2013
- Company report
- April 2013
- 17 pages
... From funding. The doc/nist will review research using human embryonic stem cell lines that it supports and conducts in accordance with the common rule and nist implementing procedures, as appropriate ...
U.s. Antibody Industry Brief
April 2013U.s. Biotechnology Business Analysis
April 2013U.s. Gmo Sector Brief
May 2013» Read our Company Profiles
22 CompaniesJohnson and Johnson
United StatesGlaxoSmithKline P.L.C.
United StatesSanofi-Aventis Senegal
SenegalBiogen Idec
United StatesAbbott Laboratories
United StatesReportlinker.com © Copyright 2013. All rights reserved.
